sub:provenance {
<
http://identifiers.org/wikipathways/WP4141_r106551>
dc:title "PI3K/AKT/mTOR - VitD3 Signalling"@en .
<
http://identifiers.org/wikipathways/WP4155_r106402>
dc:title "Endometrial cancer"@en .
<
http://identifiers.org/wikipathways/WP4172_r106516>
dc:title "PI3K-Akt Signaling Pathway"@en .
<
http://identifiers.org/wikipathways/WP4223_r106500>
dc:title "Ras Signaling"@en .
<
http://identifiers.org/wikipathways/WP4255_r105677>
dc:title "Non-small cell lung cancer"@en .
<
http://identifiers.org/wikipathways/WP4262_r105490>
dc:title "Breast cancer pathway"@en .
<
http://identifiers.org/wikipathways/WP4263_r105482>
dc:title "Pancreatic adenocarcinoma pathway"@en .
<
http://identifiers.org/wikipathways/WP4566_r104315>
dc:title "Translation inhibitors in chronically activated PDGFRA cells"@en .
<
http://identifiers.org/wikipathways/WP4582_r104340>
dc:title "Cancer immunotherapy by CTLA4 blockade"@en .
<
http://identifiers.org/wikipathways/WP481_r106617>
dc:title "Insulin Signaling"@en .
sub:assertion has-source: pmid:15805248 ,
pmid:18676830 ,
pmid:20453058 ,
pmid:26028978 , <
http://identifiers.org/wikipathways/WP4141_r106551> , <
http://identifiers.org/wikipathways/WP4155_r106402> , <
http://identifiers.org/wikipathways/WP4172_r106516> , <
http://identifiers.org/wikipathways/WP4223_r106500> , <
http://identifiers.org/wikipathways/WP4255_r105677> , <
http://identifiers.org/wikipathways/WP4262_r105490> , <
http://identifiers.org/wikipathways/WP4263_r105482> , <
http://identifiers.org/wikipathways/WP4566_r104315> , <
http://identifiers.org/wikipathways/WP4582_r104340> , <
http://identifiers.org/wikipathways/WP481_r106617> .
}